Nonlinear, Multicomponent Physical Exercise With Heart Rate Variability-Guided Prescription in Women With Breast Cancer During Treatment: Feasibility and Preliminary Results (ATOPE Study)
Metadata
Show full item recordAuthor
González Santos, Ángela; López Garzón, María de la Cabeza; Gil Gutiérrez, María del Rocío; Salinas Asensio, María del Mar; Postigo Martín, Elisa Paula; Cantarero Villanueva, IreneEditorial
Oxford University Press
Materia
Breast Neoplasms Exercise Therapy Mobile Applications Quality of Life
Date
2023-06-22Referencia bibliográfica
González Santos, Á. et al. Nonlinear, Multicomponent Physical Exercise With Heart Rate Variability-Guided Prescription in Women With Breast Cancer During Treatment: Feasibility and Preliminary Results (ATOPE Study). Physical Therapy, 2023; 103: 1–11. [https://doi.org/10.1093/ptj/pzad070]
Sponsorship
Fondos Estructurales de la Unión Europea (FEDER) (PI18/01840); Fondo de Investigación Sanitaria del Instituto de Salud Carlos III FI19/00230; Spanish Ministry of Education Cultura y Deporte FPU18/03575, FPU20/05674; European Regional Development Fund (ERDF, SOMM17/6107/UGR); University of Granada (PPJIB2021–13); Spanish Ministry of Economy and CompetitivenessAbstract
Objective. The purpose of this study was to examine the feasibility, safety, adherence, and preliminary efficacy of the ATOPE
program during radiotherapy (RT) or chemotherapy (CT) for women with breast cancer.
Methods. This single-blind, pretest–posttest feasibility study included 38 women with breast cancer at the beginning of
their treatment. The ATOPE program consisted of 12 to 18 sessions of a multimodal physical exercise program, prescribed
based on daily heart rate variability and clinimetric assessments using the ATOPE+ mHealth system. Overall health was
assessed with quality of life, autonomous balance, and body composition, whereas health-related fitness was measured
through functional capacity, physical activity levels, and upper and lower limb strength.
Results. The rates of recruitment, retention, and adherence were 52.35, 73.68, and 84.37%, respectively, and the satisfaction
rating was 9.2 out of a possible 10 points. The perceived health status change score was 3.83 points, scored on a −5 to 5
point scale. No adverse effects were found. Compliance results showed that the ATOPE+ mHealth system was used on
73.38% of the days, and the Fitbit bracelet (Google, Mountain View, CA, USA) was used on 84.91% of the days. Women
stayed physically active 55% of days. Regarding preliminary results, for overall health, the percentage of body fat in the RT
group decreased by 1.93%, whereas it increased by 5.03% in the CT group. Lower limb strength increased in the RT group,
specifically knee extensor isometric strength (6.07%), isokinetic knee flexors 180 degree/second (1.53%), and isokinetic
knee extensors 300 degree/second (4.53%), in contrast with the reductions found in the CT group (11.07, 18.67, and 14.89%,
respectively).
Conclusion. The ATOPE program, through nonlinear prescription based on daily monitoring with the ATOPE+ mHealth
system, is feasible and safe for application during breast cancer treatment. The results suggest that the overall health can be
maintained or even improved regarding most variables.
Impact. This study focused on the feasibility, safety, and completion of a physical therapist-led program at early diagnosis
for adults with breast cancer. The multimodal, supervised, tailored, nonlinear physical exercise program is feasible and safe,
showed a good completion rate, and was able to prevent the quality-of-life deficits that are often triggered by systemic breast
cancer treatment. This study highlights the importance of daily morning assessments using the ATOPE+ mHealth system
in patients with breast cancer to prescribe nonlinear physical exercise.